Director, Oncology Strategy & Investment Assessments

Pfizer Inc; New York (NY); Hybrid; USD 177,000 - 294,000; Full time

Job summary

Pfizer Inc. in the United States seeks a seasoned Director of Business Assessment to lead pipeline and BD investment analyses.

You will independently steer multiple concurrent assessments, synthesize epidemiology and market data, and deliver executive-ready recommendations to oncology leadership. You will own Operating Plan inputs and Long-Range Forecasts, collaborating with cross-functional teams across Therapeutic Areas, Finance, and Research, while guiding AI-enabled analytical workflows and

Qualifications

• BA/BS required; MBA or life sciences advanced degree preferred 8+ years in the biopharmaceutical industry, life sciences consulting, financial services, or another analytical profession
• Demonstrated ownership of patient-based revenue forecasting and business-case work from initial build to executive-ready recommendation
• Able to work with complex information — epidemiology literature, analyst reports, secondary/claims data, primary research
• Track record delivering objective investment recommendations that earn senior-leadership endorsement
• Experience coaching analytical talent, and setting methodological standards for a team
• Comfortable engaging executive commercial and research leaders at all levels
• Effective in a matrixed organization, leading cross-functional teams with indirect authority
• Business development experience across opportunity identification, commercial assessment, and high-level deal structuring
• Prior experience in biopharma forecasting, life sciences consulting, or financial services
• Oncology forecasting experience preferred; M&A or platform-evaluation experience; demonstrated use of AI/LLM tooling in analytical workflows
• Candidate demonstrates a breadth of diverse leadership experiences and capabilities

Responsibilities

• Build and own assessments of pipeline and BD opportunities, including input from internal stakeholders on development plans and commercial evaluation
• Develop analytically supported recommendations to facilitate investment trade-off decisions across opportunities
• Determine the appropriate level of rigor and external insights required depending on scenario, timeline and decision
• Conduct qualitative and quantitative market research with external physicians and key opinion leaders
• Support development of colleagues, and influence at therapeutic area or product committee level
• Take and defend an independent position before oncology leadership, including recommended decisions
• Own Oncology’s inputs to Operating Plan and Long-Range Forecast cycles, including integration of pipeline and BD forecasts
• Work flexibly across multiple therapeutic areas; maintain learning and work agility
• Set the team’s standard for AI-enabled assessment with traceable assumptions
• Occasionally support additional BA and GCA projects or enterprise initiatives using analyst reports and secondary data

Skills

Leadership experience

Forecasting revenue

Executive briefing

Strategic partnerships

Bio/pharma industry

AI/LLM tooling

Education

BA/BS required; MBA or life sciences advanced degree preferred

Tools

AI/LLM tooling

Job description

Pfizer Inc. in the United States seeks a seasoned Director of Business Assessment to lead pipeline and BD investment analyses.

You will independently steer multiple concurrent assessments, synthesize epidemiology and market data, and deliver executive-ready recommendations to oncology leadership. You will own Operating Plan inputs and Long-Range Forecasts, collaborating with cross-functional teams across Therapeutic Areas, Finance, and Research, while guiding AI-enabled analytical workflows and